Opioid Comment Letters
Submitting comment letters to various government organizations is one way that the AANA advocates for the nurse anesthesia profession. Below are recent opioid-related comment letters issued by the AANA.
Opioid Use Disorder
- AANA comment letter to the Office of National Drug Control Policy on draft report titled "Changing the Language of Addiction", November 3, 2016
- AANA comment letter to SAMHSA regarding Medication Assisted Treatment for opioid disorders, May 31, 2016
- AANA comment letter to the FDA supporting the increased public availability of naloxone to treat opioid-related overdoses and encouraging public education and awareness initiatives, August 24, 2015
Prescriber Education
- AANA comments on HHS request for information on opioid prescriber education, September 2, 2016
- AANA comment letter to FDA regarding the ER/LA Opioid Analgesics REMS Blueprint for Prescriber Education for Extended-Release and Long-Acting Opioid Analgesics, June 3, 2016
Opioid Prescribing
- AANA Comments on House Ways & Means Opioid Request, March 13, 2018
- AANA submits comment letter to the FDA's Opioid Policy Steering Committee regarding prescribing intervention strategy implementation, March 13, 2018
- AANA comments to FDA regarding the use of prescription opioids analgesics for the pediatric population, September 30, 2016
- AANA Comments to CDC on Draft Guideline for Prescribing Opioids, January 11, 2016
- AANA comments to FDA on analgesic treatment of chronic non-cancer pain, August 1, 2012
National Action Plan for Adverse Drug Event Prevention
- AANA comments to HHS on the proposed measures and 2020 targets for the National Action Plan for Adverse Drug Event Prevention, November 15, 2016
